| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 ATP7B MYO1C DNAH10 MYO7A ZGRF1 MYO19 WRN NVL MCM4 BTAF1 MSH4 DNAH14 DDX11 CLPB DDX3Y POLQ DDX11L8 ATP5F1B | 4.16e-07 | 614 | 158 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 7.77e-06 | 127 | 158 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 7.90e-06 | 262 | 158 | 11 | GO:0140097 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 9.52e-06 | 62 | 158 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | helicase activity | 3.80e-05 | 158 | 158 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP7B DNAH10 MYO19 WRN NVL MCM4 BTAF1 DDX11 CLPB DDX3Y POLQ DDX11L8 ATP5F1B | 5.07e-05 | 441 | 158 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 7.66e-05 | 11 | 158 | 3 | GO:0043139 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.58e-04 | 145 | 158 | 7 | GO:0004713 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 1.66e-04 | 14 | 158 | 3 | GO:0051880 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.26e-04 | 38 | 158 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.55e-04 | 118 | 158 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 3.69e-04 | 4 | 158 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 3.69e-04 | 4 | 158 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 3.69e-04 | 4 | 158 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | actin filament binding | 4.61e-04 | 227 | 158 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ZGRF1 POLH WRN MCM4 BTAF1 MSH4 VARS2 TEP1 DDX11 IARS2 DDX3Y POLQ DDX11L8 MPG | 6.23e-04 | 645 | 158 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | actin binding | MYH9 MYO1C TRPM7 MYO7A TPRN MYO19 MTSS1 CAMSAP3 VPS16 GAS2L1 DIAPH1 | 1.54e-03 | 479 | 158 | 11 | GO:0003779 |
| GeneOntologyBiologicalProcess | recombinational repair | 2.72e-06 | 194 | 159 | 10 | GO:0000725 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 1.57e-05 | 188 | 159 | 9 | GO:0000724 | |
| GeneOntologyBiologicalProcess | DNA recombination | REC8 ZGRF1 WRN MCM4 MSH4 INTS3 TEP1 DMAP1 RIF1 ZSWIM7 POLQ NSMCE4A | 2.95e-05 | 368 | 159 | 12 | GO:0006310 |
| GeneOntologyBiologicalProcess | DNA duplex unwinding | 3.10e-05 | 78 | 159 | 6 | GO:0032508 | |
| GeneOntologyBiologicalProcess | DNA repair | REC8 PTTG1 ZGRF1 POLH WRN MCM4 MSH4 INTS3 DMAP1 DDX11 RIF1 ZSWIM7 POLQ DDX11L8 NSMCE4A MPG | 4.26e-05 | 648 | 159 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | double-strand break repair | REC8 ZGRF1 WRN MCM4 INTS3 DMAP1 DDX11 RIF1 ZSWIM7 POLQ NSMCE4A | 4.45e-05 | 324 | 159 | 11 | GO:0006302 |
| GeneOntologyBiologicalProcess | DNA damage response | REC8 PTTG1 DCUN1D5 ZGRF1 POLH WRN MCM4 MSH4 INTS3 PPP4R3A DMAP1 DDX11 RIF1 PRKCD ZSWIM7 POLQ DDX11L8 NSMCE4A CDK6 MPG | 5.04e-05 | 959 | 159 | 20 | GO:0006974 |
| GeneOntologyBiologicalProcess | DNA geometric change | 5.40e-05 | 86 | 159 | 6 | GO:0032392 | |
| GeneOntologyBiologicalProcess | DNA conformation change | 8.89e-05 | 94 | 159 | 6 | GO:0071103 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | REC8 PTTG1 JADE3 ZGRF1 POLH WRN CAMSAP3 NVL MCM4 MSH4 INTS3 TEP1 DMAP1 DDX11 RIF1 PRKCD ZSWIM7 POLQ DDX11L8 NSMCE4A MPG | 8.89e-05 | 1081 | 159 | 21 | GO:0006259 |
| GeneOntologyBiologicalProcess | positive regulation of cell-matrix adhesion | 1.93e-04 | 69 | 159 | 5 | GO:0001954 | |
| GeneOntologyBiologicalProcess | ventricular system development | 2.05e-04 | 38 | 159 | 4 | GO:0021591 | |
| Domain | P-loop_NTPase | MYH9 RAB17 MYO1C DNAH10 MYO7A ZGRF1 MYO19 WRN NVL MCM4 BTAF1 MSH4 TEP1 PAPSS2 DNAH14 DDX11 SULT1A2 MYO15B CLPB ERAL1 DDX3Y POLQ SULT4A1 HYDIN ATP5F1B | 4.25e-08 | 848 | 157 | 25 | IPR027417 |
| Domain | - | RAB17 DNAH10 MYO7A ZGRF1 MYO19 WRN NVL MCM4 BTAF1 MSH4 TEP1 PAPSS2 DNAH14 DDX11 SULT1A2 CLPB ERAL1 DDX3Y POLQ SULT4A1 HYDIN ATP5F1B | 3.00e-07 | 746 | 157 | 22 | 3.40.50.300 |
| Domain | Myosin_head_motor_dom | 1.58e-05 | 38 | 157 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.58e-05 | 38 | 157 | 5 | PS51456 | |
| Domain | Myosin_head | 1.58e-05 | 38 | 157 | 5 | PF00063 | |
| Domain | MYSc | 1.58e-05 | 38 | 157 | 5 | SM00242 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 4.30e-05 | 23 | 123 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 5.12e-05 | 24 | 123 | 4 | M16289 | |
| Pubmed | 3.96e-08 | 202 | 161 | 10 | 24639526 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPD2 MYH9 CAD MYO1C DNAH10 COPB1 NOL6 MCM4 PRPF8 UBE4A RIF1 IARS2 KIDINS220 CLPB ERAL1 RPF2 DOCK7 DIAPH1 GEMIN4 CPSF1 PRKCD MAP4K4 ATP5F1B | 1.94e-07 | 1425 | 161 | 23 | 30948266 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | DCUN1D5 COPB1 CENPC JADE3 NOL6 NVL VPS16 INTS3 DMAP1 RIF1 SULT1A2 RPF2 INTS9 MPG | 2.15e-07 | 533 | 161 | 14 | 30554943 |
| Pubmed | REC8 MYH9 CAD ZFAT CENPC TRPM7 VARS2 VPS16 MED13L PAPSS2 TTK PPP4R4 DMAP1 UBE4A SCAP CLPB MTF1 CLVS2 CPSF1 R3HDM1 MAP4K4 CDK6 | 2.33e-07 | 1327 | 161 | 22 | 32694731 | |
| Pubmed | MYH9 CAD MYO1C COPB1 NOL6 NVL MCM4 PRPF8 USP5 RIF1 IARS2 RPF2 DOCK7 GEMIN4 CPSF1 | 4.29e-07 | 653 | 161 | 15 | 22586326 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 4.69e-07 | 202 | 161 | 9 | 33005030 | |
| Pubmed | CAD COPB1 ARHGAP26 CAMSAP3 CCDC175 BTAF1 VPS16 MED13L INTS3 RIF1 | 6.24e-07 | 272 | 161 | 10 | 31010829 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 CAD MYO1C COPB1 CENPC MYO19 NOL6 MCM4 VPS16 PRPF8 PAPSS2 USP5 RIF1 ERAL1 RPF2 DIAPH1 GEMIN4 CPSF1 PRKCD ATP5F1B MPG | 1.29e-06 | 1353 | 161 | 21 | 29467282 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH9 MYO1C COPB1 MYO7A ZGRF1 MCM4 VPS16 PRPF8 PPP4R3A USP5 CLPB LPCAT2 RABGAP1L LRP5 MAP4K4 ATP5F1B | 2.25e-06 | 847 | 161 | 16 | 35235311 |
| Pubmed | GPD2 MYO1C COPB1 MCM4 VPS16 PRPF8 GPKOW PPP4R3A DMAP1 UBE4A HAUS4 DIAPH1 CKAP2 | 2.32e-06 | 560 | 161 | 13 | 35241646 | |
| Pubmed | 2.83e-06 | 251 | 161 | 9 | 29778605 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MYH9 HTRA1 SYT12 AXL PODXL2 DMAP1 USP5 POGLUT1 SCAP TMTC3 CELSR2 LPCAT2 CPSF1 LRP5 CKAP2 R3HDM1 NOTCH3 ATP5F1B MPG | 3.28e-06 | 1201 | 161 | 19 | 35696571 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MYH9 COPB1 BTAF1 PRPF8 INTS3 TTK RIF1 PPP2R1B MYO15B ERAL1 DIAPH1 GEMIN4 CPSF1 | 3.53e-06 | 582 | 161 | 13 | 20467437 |
| Pubmed | KDM5B MYH9 ZGRF1 POLH LIN54 CAMSAP3 BCR WDCP DOCK7 GEMIN4 CSTPP1 | 4.40e-06 | 418 | 161 | 11 | 34709266 | |
| Pubmed | MYO1C COPB1 MYO19 MCM4 BCR TTK RIF1 IARS2 KIDINS220 ERAL1 CPSF1 INTS9 NSMCE4A | 5.46e-06 | 606 | 161 | 13 | 36538041 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | GPD2 CAD MYO1C TRPM7 SYNM MYO19 VARS2 TTK UBE4A IARS2 CLPB ERAL1 SURF1 RPF2 GEMIN4 CPSF1 PRKCD CKAP2 R3HDM1 CSTPP1 ATP5F1B | 6.16e-06 | 1496 | 161 | 21 | 32877691 |
| Pubmed | 7.56e-06 | 214 | 161 | 8 | 22199357 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | KRT13 ARHGAP26 WRN MED13L PRPF8 KLHL22 YOD1 KIDINS220 ERAL1 DOCK7 PRKCD C3 CKAP2 ATP5F1B | 8.67e-06 | 732 | 161 | 14 | 34732716 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | UNC119B MYH9 CAD MYO1C COPB1 TPRN NOL6 MCM4 PRPF8 DOCK7 GEMIN4 CPSF1 DDX3Y C3 GFPT2 MPG | 9.40e-06 | 949 | 161 | 16 | 36574265 |
| Pubmed | MYO19 NOL6 CAMSAP3 BTAF1 INTS3 PAPSS2 BCR DENND3 WDCP DOCK7 HSD17B11 MAP4K4 DDX11L8 | 1.15e-05 | 650 | 161 | 13 | 38777146 | |
| Pubmed | MYH9 COPB1 MORN1 SYNM MCM4 BTAF1 PRPF8 RIF1 CLPB RPF2 DOCK7 CPSF1 GFPT2 | 1.21e-05 | 653 | 161 | 13 | 33742100 | |
| Pubmed | MYH9 CAD NUP210L NOL6 MCM4 PRPF8 BCR DMAP1 USP5 SCAP RFLNB CLPB ERAL1 CPSF1 | 1.21e-05 | 754 | 161 | 14 | 35906200 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 1.31e-05 | 166 | 161 | 7 | 35687106 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GPD2 MYH9 MYO1C COPB1 AXL MCM4 VARS2 PRPF8 PPP4R3A HAUS4 IARS2 POGLUT1 TMTC3 CELSR2 ASXL3 CPSF1 GFPT2 HSD17B11 MAP4K4 ATP5F1B | 1.36e-05 | 1451 | 161 | 20 | 30550785 |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | MYH9 CAD MYO1C COPB1 MCM4 PPP2R1B IARS2 TMTC3 ERAL1 DDX3Y HSD17B11 ATP5F1B | 1.40e-05 | 565 | 161 | 12 | 33567341 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CAD MYO1C TPRN PRPF8 INTS3 PPP4R3A DMAP1 RIF1 PPP2R1B GEMIN4 INTS9 ATP5F1B | 1.61e-05 | 573 | 161 | 12 | 28330616 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PTTG1 MYO1C JADE3 CAMSAP3 MCM4 BTAF1 INTS3 PPP4R3A STK10 RIF1 CPSF1 PRKCD MAP4K4 MPG | 1.61e-05 | 774 | 161 | 14 | 15302935 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.67e-05 | 313 | 161 | 9 | 38270169 | |
| Pubmed | MYH9 MYO1C DSCAM COPB1 TRPM7 SYNM LIN54 NOL6 WRN PODXL2 RIF1 IARS2 KIDINS220 DOCK7 | 1.68e-05 | 777 | 161 | 14 | 35844135 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM5B MYH9 MYO1C NOL6 WRN MCM4 PRPF8 BCR KLHL22 YOD1 USP5 PPP2R1B CLPB RPF2 DOCK7 MAP4K4 | 1.90e-05 | 1005 | 161 | 16 | 19615732 |
| Pubmed | UNC119B KRT13 CAD CENPC TRPM7 SYNM NVL VARS2 PRPF8 TTK UBE4A IARS2 KIDINS220 TMTC3 CLPB ERAL1 RPF2 CKAP2 MAP4K4 ATP5F1B | 1.93e-05 | 1487 | 161 | 20 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RAB17 MORN1 FRMPD2 CAMSAP3 BTAF1 ADGRV1 INTS3 TEP1 BCR DNAH14 PPM1H PPP4R4 STK10 PPP2R1B POGLUT1 KIDINS220 RPF2 LRP5 CKAP2 NOTCH3 | 1.97e-05 | 1489 | 161 | 20 | 28611215 |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 8836137 | ||
| Pubmed | Preeclampsia and Related Cardiovascular Risk: Common Genetic Background. | 2.13e-05 | 2 | 161 | 2 | 29971632 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 25483078 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 30859180 | ||
| Pubmed | Werner syndrome protein interacts functionally with translesion DNA polymerases. | 2.13e-05 | 2 | 161 | 2 | 17563354 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 29955124 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 26091161 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 23841513 | ||
| Pubmed | Reevaluation of the role of DNA polymerase theta in somatic hypermutation of immunoglobulin genes. | 2.13e-05 | 2 | 161 | 2 | 18485835 | |
| Pubmed | sVEGF R1 and Tie-2 levels during chemotherapy of lung cancer patients. | 2.13e-05 | 2 | 161 | 2 | 22836649 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 17449470 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | MYH9 CAD DCUN1D5 COPB1 MCM4 ADGRV1 DCUN1D4 PPP4R3A KLHL22 DIAPH1 ATP5F1B | 2.13e-05 | 495 | 161 | 11 | 28581483 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYH9 KRT13 MYO1C COPB1 GATM PRPF8 PPP4R3A PPP2R1B VCAN GEMIN4 CDK6 | 2.25e-05 | 498 | 161 | 11 | 36634849 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.75e-05 | 256 | 161 | 8 | 33397691 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | DCUN1D5 CENPC JADE3 POLH LIN54 WRN NVL BTAF1 GPKOW DMAP1 RIF1 MPG | 2.87e-05 | 608 | 161 | 12 | 36089195 |
| Pubmed | KDM5B DSCAM COPB1 TRPM7 SYNM GATM MED13L PRPF8 DMAP1 UBE4A CLPB HECTD2 GFPT2 CKAP2 R3HDM1 SULT4A1 MAP4K4 ATP5F1B | 3.06e-05 | 1285 | 161 | 18 | 35914814 | |
| Pubmed | GPD2 MYH9 HTRA1 CAD MYO1C COPB1 MYO7A ARHGAP26 NCKIPSD CAMSAP3 BCR GAS2L1 USP5 KIDINS220 MTERF2 VCAN DOCK7 DDX3Y ATP5F1B | 3.77e-05 | 1431 | 161 | 19 | 37142655 | |
| Pubmed | ATP7B DCUN1D5 NVL BCR GPKOW AFAP1L1 IARS2 SCAP TMTC3 DIAPH1 CKAP2 R3HDM1 MAP4K4 | 4.00e-05 | 733 | 161 | 13 | 34672954 | |
| Pubmed | GPD2 CAD MYO1C COPB1 MYO19 NOL6 BTAF1 PRPF8 UBE4A USP5 PPP2R1B IARS2 RFLNB CLPB ERAL1 RPF2 DOCK7 GEMIN4 ATP5F1B | 4.10e-05 | 1440 | 161 | 19 | 30833792 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.21e-05 | 440 | 161 | 10 | 34244565 | |
| Pubmed | 4.25e-05 | 15 | 161 | 3 | 10022836 | ||
| Pubmed | CAD COPB1 MCM4 PRPF8 PPP4R3A USP5 RIF1 ERAL1 RPF2 DIAPH1 GEMIN4 ATP5F1B | 4.56e-05 | 638 | 161 | 12 | 33239621 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ARHGAP26 MCM4 PRPF8 BCR PPP4R3A USP5 PPP2R1B KIDINS220 TMTC3 CLPB ERAL1 GEMIN4 PRMT9 C3 ATP5F1B | 5.09e-05 | 974 | 161 | 15 | 28675297 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B TRPM7 NCKIPSD CAMSAP3 BCR TTK PPM1H PPP4R4 STOX2 RABGAP1L DOCK7 CKAP2 R3HDM1 MAP4K4 | 5.14e-05 | 861 | 161 | 14 | 36931259 |
| Pubmed | 5.20e-05 | 44 | 161 | 4 | 26471122 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 5.47e-05 | 454 | 161 | 10 | 33226137 | |
| Pubmed | 5.68e-05 | 45 | 161 | 4 | 22114352 | ||
| Pubmed | 5.72e-05 | 284 | 161 | 8 | 29459677 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 18394644 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 15817662 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 17611414 | ||
| Pubmed | Target cell frequency is a genetically determined risk factor in radiation leukaemogenesis. | 6.37e-05 | 3 | 161 | 2 | 17704327 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 21854770 | ||
| Pubmed | Ufd2, a novel autoantigen in scleroderma, regulates sister chromatid separation. | 6.37e-05 | 3 | 161 | 2 | 15611659 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 27856601 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 23754286 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 32328755 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 17050716 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 29142287 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 15976448 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 21402993 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | MYH9 KRT13 CAD MYO1C LIN54 LPCAT2 VCAN GEMIN4 C3 MAP4K4 ATP5F1B | 6.91e-05 | 564 | 161 | 11 | 21565611 |
| Pubmed | 7.55e-05 | 18 | 161 | 3 | 33842485 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 KRT13 CAD MYO1C SYNM NOL6 PRPF8 GPKOW AFAP1L1 IARS2 RPF2 DOCK7 GEMIN4 CPSF1 C3 CKAP2 ATP5F1B | 7.91e-05 | 1257 | 161 | 17 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CAD MYO1C COPB1 MCM4 BTAF1 PRPF8 DDX11 RIF1 PPP2R1B IARS2 CLPB ERAL1 GEMIN4 CPSF1 DDX3Y HSD17B11 ATP5F1B | 7.91e-05 | 1257 | 161 | 17 | 37317656 |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 8.77e-05 | 302 | 161 | 8 | 30561431 | |
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 8.93e-05 | 19 | 161 | 3 | 14578343 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CAD ZGRF1 TPRN LIN54 BCR TTK PPP4R3A DDX11 HAUS4 WDCP DIAPH1 | 9.98e-05 | 588 | 161 | 11 | 38580884 |
| Pubmed | PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. | 1.05e-04 | 20 | 161 | 3 | 18715871 | |
| Pubmed | STARD8 SYNM VARS2 DENND3 PPP4R4 PPP4R3A UBE4A MYO15B SCAP UNC80 | 1.08e-04 | 493 | 161 | 10 | 15368895 | |
| Pubmed | CAD MYO7A PPP4R3A USP5 RPF2 DIAPH1 GEMIN4 MROH7 POLQ ATP5F1B | 1.13e-04 | 496 | 161 | 10 | 31343991 | |
| Pubmed | MYH9 CAD COPB1 VPS16 PRPF8 PAPSS2 ERAL1 DOCK7 C3 MAP4K4 ATP5F1B | 1.21e-04 | 601 | 161 | 11 | 33658012 | |
| Pubmed | GPD2 MYH9 CAD COPB1 MCM4 TTK KIDINS220 DOCK7 GEMIN4 MAP4K4 CSTPP1 ATP5F1B | 1.22e-04 | 708 | 161 | 12 | 39231216 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 23209669 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 16720305 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 34187556 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 20164029 | ||
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 1.27e-04 | 4 | 161 | 2 | 18463160 | |
| Pubmed | TRPM7, a novel regulator of actomyosin contractility and cell adhesion. | 1.27e-04 | 4 | 161 | 2 | 16407977 | |
| Pubmed | Determination of a gene and environment risk model for age-related macular degeneration. | 1.27e-04 | 4 | 161 | 2 | 20576771 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 31970928 | ||
| Pubmed | Proteomic and genomic biomarkers for age-related macular degeneration. | 1.27e-04 | 4 | 161 | 2 | 20238042 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 23337555 | ||
| Pubmed | Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta. | 1.27e-04 | 4 | 161 | 2 | 9285590 | |
| Pubmed | Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. | 1.27e-04 | 4 | 161 | 2 | 19202148 | |
| Pubmed | Whole-exome sequencing of Finnish patients with vascular cognitive impairment. | 1.27e-04 | 4 | 161 | 2 | 33268848 | |
| Pubmed | LRP5 regulates development of lung microvessels and alveoli through the angiopoietin-Tie2 pathway. | 1.27e-04 | 4 | 161 | 2 | 22848540 | |
| Pubmed | Depletion of WRN protein causes RACK1 to activate several protein kinase C isoforms. | 1.27e-04 | 4 | 161 | 2 | 19966859 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | REC8 PTTG1 RCCD1 ZGRF1 MYO19 POLH LIN54 NCKIPSD MCM4 TTK DDX11 USP5 RIF1 HAUS4 RFLNB CKAP2 R3HDM1 POLQ MAP4K4 | 5.42e-06 | 939 | 161 | 19 | M45768 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | REC8 PTTG1 CENPC RCCD1 ZGRF1 MYO19 LIN54 NCKIPSD NVL MCM4 VPS16 TTK KLHL22 DDX11 USP5 PPP2R1B CLPB ERAL1 GEMIN4 INTS9 ELF4 CKAP2 POLQ NSMCE4A | 6.66e-06 | 1423 | 161 | 24 | M45722 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | KDM5B HTRA1 JADE3 MYO7A SYNM AXL ARHGAP26 CAMSAP3 GATM PAPSS2 PPP4R4 RIF1 IARS2 SCAP LPCAT2 HECTD2 VCAN DOCK7 PRKCD DDX3Y ELF4 | 2.71e-06 | 880 | 159 | 21 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.83e-08 | 199 | 161 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.04e-08 | 200 | 161 | 9 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-07 | 184 | 161 | 8 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.70e-07 | 184 | 161 | 8 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 3.70e-07 | 184 | 161 | 8 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.70e-07 | 184 | 161 | 8 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.70e-07 | 184 | 161 | 8 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.53e-07 | 189 | 161 | 8 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 5.97e-07 | 196 | 161 | 8 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.70e-07 | 199 | 161 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.70e-07 | 199 | 161 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.70e-07 | 199 | 161 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.95e-07 | 200 | 161 | 8 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-07 | 200 | 161 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.95e-07 | 200 | 161 | 8 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.95e-07 | 200 | 161 | 8 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.95e-07 | 200 | 161 | 8 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-07 | 200 | 161 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.95e-07 | 200 | 161 | 8 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.95e-07 | 200 | 161 | 8 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.21e-07 | 138 | 161 | 7 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 2.02e-06 | 161 | 161 | 7 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 2.02e-06 | 161 | 161 | 7 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-06 | 163 | 161 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-06 | 177 | 161 | 7 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-06 | 177 | 161 | 7 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 4.24e-06 | 180 | 161 | 7 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.72e-06 | 183 | 161 | 7 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-06 | 184 | 161 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-06 | 184 | 161 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-06 | 184 | 161 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 4.90e-06 | 184 | 161 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.90e-06 | 184 | 161 | 7 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.07e-06 | 185 | 161 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.07e-06 | 185 | 161 | 7 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-06 | 187 | 161 | 7 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 5.64e-06 | 188 | 161 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.64e-06 | 188 | 161 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.84e-06 | 189 | 161 | 7 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.84e-06 | 189 | 161 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 5.84e-06 | 189 | 161 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-06 | 190 | 161 | 7 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 6.04e-06 | 190 | 161 | 7 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 192 | 161 | 7 | 9d53b42cdb537b30233cdfdc08052c8b13a1113f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 192 | 161 | 7 | 042391162df2e3d0027688dd14163c4c6821afe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 192 | 161 | 7 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 192 | 161 | 7 | 71b0bfee0461ff64cef35881db3959c517e9731b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 192 | 161 | 7 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 192 | 161 | 7 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.69e-06 | 193 | 161 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.69e-06 | 193 | 161 | 7 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 6.92e-06 | 194 | 161 | 7 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-06 | 196 | 161 | 7 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.65e-06 | 197 | 161 | 7 | 50f994e0d4e69019ec92e164edf3e4e951333766 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 199 | 161 | 7 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 199 | 161 | 7 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.17e-06 | 199 | 161 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.45e-06 | 200 | 161 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.45e-06 | 200 | 161 | 7 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.48e-05 | 159 | 161 | 6 | 31ec8222c766cb614e1cf27f74ee9d99489eca5c | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 161 | 161 | 6 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.76e-05 | 162 | 161 | 6 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 3.27e-05 | 167 | 161 | 6 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-05 | 168 | 161 | 6 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 169 | 161 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 171 | 161 | 6 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 171 | 161 | 6 | d1e87478d8c0329e662849823f5c7604f20e1b1a | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 171 | 161 | 6 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 171 | 161 | 6 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-05 | 171 | 161 | 6 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | RSV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 4.25e-05 | 175 | 161 | 6 | c47440c0b0513e67fe13b85f10dd8a8d42d0e9a3 | |
| ToppCell | RSV-Healthy-2|RSV / Virus stimulation, Condition and Cluster | 4.25e-05 | 175 | 161 | 6 | 0e97189585b7afaf3bd622c3ef10c86412393829 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.25e-05 | 175 | 161 | 6 | 7be76d39e1a4f4ac709672cd2d409a2523a083ce | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.39e-05 | 176 | 161 | 6 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 177 | 161 | 6 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 177 | 161 | 6 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 178 | 161 | 6 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.82e-05 | 179 | 161 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 180 | 161 | 6 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.97e-05 | 180 | 161 | 6 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-05 | 180 | 161 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.97e-05 | 180 | 161 | 6 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.29e-05 | 182 | 161 | 6 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.45e-05 | 183 | 161 | 6 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 5.62e-05 | 184 | 161 | 6 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 5.62e-05 | 184 | 161 | 6 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 185 | 161 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.79e-05 | 185 | 161 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.79e-05 | 185 | 161 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.79e-05 | 185 | 161 | 6 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.79e-05 | 185 | 161 | 6 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 5.96e-05 | 186 | 161 | 6 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.14e-05 | 187 | 161 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 187 | 161 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.14e-05 | 187 | 161 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 188 | 161 | 6 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-05 | 188 | 161 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 188 | 161 | 6 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-05 | 188 | 161 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| Disease | CADASIL Syndrome | 2.71e-05 | 2 | 154 | 2 | C0751587 | |
| Disease | CADASILM | 2.71e-05 | 2 | 154 | 2 | C1449626 | |
| Disease | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | 2.71e-05 | 2 | 154 | 2 | cv:C0751587 | |
| Disease | age related macular degeneration 7 (is_implicated_in) | 2.71e-05 | 2 | 154 | 2 | DOID:0110019 (is_implicated_in) | |
| Disease | DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder) | 8.09e-05 | 3 | 154 | 2 | C1852282 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 8.98e-05 | 17 | 154 | 3 | DOID:10873 (is_implicated_in) | |
| Disease | Transitional cell carcinoma of bladder | 1.61e-04 | 4 | 154 | 2 | C0279680 | |
| Disease | urinary potassium to creatinine ratio | 4.00e-04 | 6 | 154 | 2 | EFO_0009882 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 4.61e-04 | 29 | 154 | 3 | cv:C5779548 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 6.78e-04 | 33 | 154 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | Nonsyndromic genetic hearing loss | 6.84e-04 | 76 | 154 | 4 | cv:C5680182 | |
| Disease | lactase-phlorizin hydrolase measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0801753 | |
| Disease | glycine measurement | 7.79e-04 | 137 | 154 | 5 | EFO_0009767 | |
| Disease | alpha-1-antitrypsin measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0008327 | |
| Disease | Hereditary hearing loss and deafness | 1.04e-03 | 146 | 154 | 5 | cv:C0236038 | |
| Disease | response to radiation, Abnormality of the urinary system | 1.18e-03 | 10 | 154 | 2 | GO_0009314, HP_0000079 | |
| Disease | age-related macular degeneration, disease progression measurement | 1.28e-03 | 41 | 154 | 3 | EFO_0001365, EFO_0008336 | |
| Disease | Malignant neoplasm of breast | FLT1 MYH9 STARD8 ATP7B RCCD1 POLH EFCAB13 TEK RIF1 WDCP SURF1 MROH7 ADGRF4 NOTCH3 | 1.54e-03 | 1074 | 154 | 14 | C0006142 |
| Disease | hearing impairment | 1.76e-03 | 98 | 154 | 4 | C1384666 | |
| Disease | cholesterol in medium LDL measurement | 2.15e-03 | 49 | 154 | 3 | EFO_0022224 | |
| Disease | Impaired cognition | 2.36e-03 | 14 | 154 | 2 | C0338656 | |
| Disease | total lipids in medium LDL | 2.55e-03 | 52 | 154 | 3 | EFO_0022180 | |
| Disease | cardiovascular disease | 2.85e-03 | 457 | 154 | 8 | EFO_0000319 | |
| Disease | triglycerides in medium VLDL measurement | 3.00e-03 | 55 | 154 | 3 | EFO_0022155 | |
| Disease | Chromosome Aberrations | 3.10e-03 | 16 | 154 | 2 | C0008625 | |
| Disease | Autosome Abnormalities | 3.10e-03 | 16 | 154 | 2 | C0004403 | |
| Disease | serum gamma-glutamyl transferase measurement | UNC119B SYT12 TRPM7 NUP210L AXL CYP21A2 UBE4A CELSR2 C3 IGSF21 EPHA1 CDK6 | 3.14e-03 | 914 | 154 | 12 | EFO_0004532 |
| Disease | Dementia | 3.50e-03 | 17 | 154 | 2 | C0497327 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.50e-03 | 17 | 154 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Van Buchem disease | 3.50e-03 | 17 | 154 | 2 | C0432272 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 3.50e-03 | 17 | 154 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | pain | 3.74e-03 | 196 | 154 | 5 | EFO_0003843 | |
| Disease | lean body mass | 3.87e-03 | 379 | 154 | 7 | EFO_0004995 | |
| Disease | Age-related macular degeneration | 3.92e-03 | 18 | 154 | 2 | cv:C0242383 | |
| Disease | Tourette syndrome, schizophrenia | 3.92e-03 | 18 | 154 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | Hemangiosarcoma | 3.92e-03 | 18 | 154 | 2 | C0018923 | |
| Disease | serum metabolite measurement | GPD2 UNC119B CYP21A2 GATM TEK PAPSS2 STAC SULT1A2 CELSR2 RABGAP1L DOCK7 PRKCD | 4.10e-03 | 945 | 154 | 12 | EFO_0005653 |
| Disease | Cerebrovascular accident | 4.21e-03 | 62 | 154 | 3 | C0038454 | |
| Disease | cutaneous melanoma, hair color | 4.21e-03 | 62 | 154 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.37e-03 | 19 | 154 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 4.37e-03 | 19 | 154 | 2 | MONDO_0018469 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 4.40e-03 | 63 | 154 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | cholesterol in large VLDL measurement | 4.81e-03 | 65 | 154 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.81e-03 | 65 | 154 | 3 | EFO_0022230 | |
| Disease | serum homoarginine measurement | 4.83e-03 | 20 | 154 | 2 | EFO_0005421 | |
| Disease | Disorder of eye | 5.20e-03 | 212 | 154 | 5 | C0015397 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGENLPIEDRETIIM | 321 | P30154 | |
| EREDQLVPGQLVAML | 716 | P21709 | |
| DIGVEPENVVMLVLA | 131 | Q92564 | |
| LPMVVVRVELLSGEI | 291 | Q99424 | |
| LDNPIQVEMGEELVL | 816 | Q6P2P2 | |
| EQIEVGPLVTSMEIL | 491 | P13611 | |
| PRMELRSVGDIEQEL | 21 | P11274 | |
| REEQVPMELVQRGDI | 816 | P35670 | |
| TEDILGMVQIPRQEL | 266 | Q8IZF3 | |
| VRRPGMEIAEIMIEE | 3891 | Q8WXG9 | |
| VEEDVGLIMIPVVRL | 4411 | Q8WXG9 | |
| PNILRLESEETMVLE | 31 | P01024 | |
| EEGMPLSTIREVAVL | 51 | Q00534 | |
| VLMDVSRRENGEILP | 2361 | Q9HCU4 | |
| ETEEGILLLVRAMDP | 236 | O60610 | |
| TLEPEEVVNRLMHGI | 236 | Q8NBQ5 | |
| AEQAPELMRLISEIL | 611 | A2RUS2 | |
| DVDVVMGDPVLLRSV | 416 | Q9P1Y5 | |
| DIGVEPENIIMLVLA | 76 | Q9BTE7 | |
| GEFTPEMQLRIRQEI | 326 | Q9C0F0 | |
| LGRIMNVIGEPIDER | 141 | P06576 | |
| GAQPIEEMRHTIVDI | 491 | Q8WWK9 | |
| RHRALEVIPEIMQGI | 736 | Q68CQ1 | |
| VLEITELPDGITRME | 986 | Q15032 | |
| PRLLEALQGLVMAEV | 201 | A6NED2 | |
| LEEELHPGEVLVMLV | 116 | Q9H0T7 | |
| ILEAEPIRMLEIEGE | 196 | O95072 | |
| PDETLRSGELLNMIV | 751 | Q68E01 | |
| TEPTVQIGRLLMEEL | 126 | Q9NV88 | |
| LEDIREELTMAILAP | 586 | O15381 | |
| VQLMGLLRTLVDPEN | 446 | Q6IN85 | |
| ILEDLPIQSGDMLII | 106 | Q5VVQ6 | |
| AEQATRIVILGPEVM | 211 | Q5T089 | |
| LEVIGRLPDMEMVIN | 116 | Q8NBL1 | |
| VVPTQDVLSMLGDIR | 456 | Q9NZ53 | |
| PEDIDQLITISGMVI | 276 | P33991 | |
| LLDDGVINMSIPIVL | 286 | O95340 | |
| AIIILPNTDGMELLV | 1121 | O95819 | |
| EMEGIRETSQVILRP | 1701 | Q9ULH0 | |
| AEEALPRIVELMGRE | 566 | P43304 | |
| LLPEEIMDTGITLVD | 11 | Q6MZP7 | |
| LVGQRLPLMAEVSET | 601 | Q71F56 | |
| AMPRDILIVVGNEII | 166 | P50440 | |
| GRVIQIVLMRAAEEP | 66 | Q05655 | |
| SLLGLPEDVLLEMVQ | 336 | Q96H55 | |
| MEGLLVPEETLRELL | 556 | Q99607 | |
| LTDPVERGMRVIEIS | 121 | Q2TAP0 | |
| MRVILILDPAISGNE | 2206 | O43451 | |
| SNALMLLRPEEVEIL | 646 | Q5U5R9 | |
| ASRDVIIDQLPDLMG | 576 | O75197 | |
| PGIDLTRVLAEMREQ | 266 | P13646 | |
| RGRILIMDVIEVVPE | 1136 | Q10570 | |
| ALLLGIRDSMEPVVE | 126 | P08686 | |
| IEIATVMPSGNRELL | 56 | Q99645 | |
| MPTVLGVLLLDQREI | 76 | Q9Y5P0 | |
| MLRPVIEEEISMLGE | 201 | O43312 | |
| MTEIRRSLGEIPIVE | 476 | P53618 | |
| DMPENSRVLRVVLLG | 106 | O75616 | |
| GELVMVPNVEAILED | 1111 | Q9H6R4 | |
| RELAPEVIGSVVMLE | 1571 | Q9UM47 | |
| IDRLQDAGIEPMATL | 481 | P09848 | |
| VEGLDPDNVRAMVRL | 261 | Q92917 | |
| VLEGLREDMLETLVP | 401 | Q92917 | |
| DVELPQLAEMRIRLE | 901 | Q9UGL1 | |
| IPEEEQMGLLRVISG | 331 | P35579 | |
| EMLETGPEAERLEQL | 176 | Q96FC9 | |
| DMVVTEVVEPVRFLL | 396 | Q5R372 | |
| VPVLEERMQGLLREG | 296 | Q49AM1 | |
| VRNLMAEALGIPVTD | 306 | Q7L5N7 | |
| ALERVPSMELGRLEI | 416 | Q96JP2 | |
| ELVLERVPAELNGSM | 396 | Q96ID5 | |
| MLSIGIEEVFDILPL | 1321 | Q4G0P3 | |
| VVRRGNEDIMITVIP | 461 | Q92743 | |
| LETVRFPLMEAEVLQ | 241 | Q53GT1 | |
| EEIILTPIEVAIEDM | 1986 | Q96N67 | |
| RQVLEELTELPVMVE | 386 | O94808 | |
| AMDEELERLLAQVPG | 266 | Q9H6J7 | |
| LLVVPVLGRMSDQTD | 1186 | O14981 | |
| SLEGLRLLVEQESPM | 751 | P0C221 | |
| ETREIILMDLVRPQD | 831 | Q03188 | |
| LEQMLLELGVELSPT | 341 | Q9NPF5 | |
| RVELGVPEVLMFETE | 111 | Q99501 | |
| VPEVLMFETEDLVLR | 116 | Q99501 | |
| EELDMAGVQSLVPRL | 906 | Q68DX3 | |
| MEELADLVGVRPNLL | 436 | P49326 | |
| ELLEVMDQLRRLPSG | 386 | O75417 | |
| EMLETGPEAERLEQL | 176 | A8MPP1 | |
| LRALEPLEGLETMRQ | 181 | P29372 | |
| TLVTEMQEELLILGP | 2271 | Q0VDD8 | |
| LDSMGIPINREILEE | 246 | Q8IY85 | |
| AQGEAMRAVLIPIRE | 251 | Q17RN3 | |
| PDVLTIMLQLFDEGR | 461 | Q9H078 | |
| IEMLRVLEEDPQVGG | 226 | O00219 | |
| VTELMRLLGPSQERE | 121 | Q9H6D7 | |
| LDMGFEPQIRRIVEQ | 351 | O15523 | |
| EIKLEMPIISVEGEV | 221 | Q8IVF4 | |
| EIVPLVLRGHLMDIE | 766 | Q12770 | |
| EEAIVILQGQPEMLL | 216 | Q6ZTR5 | |
| VRVEDVAAELGMPTL | 411 | Q92613 | |
| ADVEIGQIIEIPIAM | 556 | Q5VU65 | |
| LSGVPLMILDEEREL | 141 | O95997 | |
| LVTEVRGMQEAPEAI | 126 | P01236 | |
| DIPRAQLLIEERDTM | 1661 | O60469 | |
| VLDPRDIISGVEMQV | 666 | Q5ST30 | |
| FMRVSLLPDEQIVGI | 191 | Q8IV01 | |
| MEDLQELTIIERPVR | 21 | Q6NUP7 | |
| DLVGIVPLAMDTEIL | 426 | Q8N3T6 | |
| EVIGQLEETLPERMR | 951 | O15061 | |
| RLNGVLMEVEEPEVL | 1031 | P0DPF3 | |
| MVGRLSLQDVPELVD | 1 | Q8N5W9 | |
| IVRLIEQAPIQMGEE | 166 | Q5UIP0 | |
| NLIPIEALLQGEEEM | 731 | Q14872 | |
| IVDLGGLPIMVNILD | 531 | Q5T2S8 | |
| LLRPQEETVAAIMDI | 536 | Q9UNA1 | |
| LDTGEQLMVPVEVLE | 71 | Q8N5S1 | |
| LEPLVDIETINMRLD | 356 | O15457 | |
| MGVNPLEAEELIRDE | 171 | Q9NXX6 | |
| IGLVISPLISLMEDQ | 591 | Q14191 | |
| PDLQLTVGAVIVEEM | 186 | Q9Y253 | |
| VDLIGMVRLTETRQP | 201 | Q15526 | |
| VIEPGLLFEIIEMLQ | 906 | Q9NSE4 | |
| ELPEVIRAFMGLEEN | 176 | Q969I6 | |
| MLDLEVVPERSLGNE | 1 | Q9BSU1 | |
| AAVPRTIGAELMELV | 306 | Q9NZQ3 | |
| LLRAQVLEALMPGVE | 891 | Q92502 | |
| RIELEEMGPSLDLVL | 211 | Q9H7B2 | |
| MDRGQVLEQLLPELT | 1 | Q8TED9 | |
| IQEVRDMVITRPDIG | 31 | Q5SYC1 | |
| QEIDDVIGQVRRPEM | 351 | A0A087X1C5 | |
| EIRDIILGMEISAPS | 2006 | Q6P2Q9 | |
| IVQELRGSILDAMRP | 201 | Q6PCB0 | |
| MEEGVNVDEIIIPLR | 36 | Q9P243 | |
| VLPIVHLMEDGEVRE | 1851 | Q8N2C7 | |
| MAVVLPAVVEELLSE | 1 | Q19AV6 | |
| RVPVDRVILLGQSMD | 776 | Q99973 | |
| EIGLMNIDEQLPVLE | 76 | Q9BR01 | |
| AIIIRNGEIIPMSSE | 291 | Q9ULR3 | |
| GIPDVVVEMAEADLR | 346 | Q9UBI4 | |
| EMEIIRRINPDLTVE | 311 | Q9P2F5 | |
| VGRSLPEETVDLMVE | 211 | P50226 | |
| VVQHLPLELMDGVVR | 236 | Q9P2H5 | |
| IMLELDRGLTEPQIQ | 121 | O94804 | |
| NEDLEMRPGDIITLL | 301 | Q99469 | |
| ERRLMVVGDAPESIQ | 286 | Q9H269 | |
| PRMEEVTLSEVVRVG | 156 | A1A519 | |
| EFPQLSEDVIRLMIE | 206 | A6NIH7 | |
| TPEVLMDIGLRQEVT | 376 | P30530 | |
| VLQELLMGVLTPERT | 566 | Q8TBZ2 | |
| EREGIQRMTPKIVDL | 341 | Q02763 | |
| ALATRVIMGEEVEPV | 1236 | P27708 | |
| VMETIPLGDLQARAL | 306 | Q4KMQ1 | |
| ERGAVPLEMLEIALR | 171 | P33981 | |
| EILIAPVDEMGIIRL | 156 | Q6P2C0 | |
| LMNGVTEIERSPLLE | 1896 | Q86YA3 | |
| LILDEEVRTFPEVMI | 256 | Q14139 | |
| MGTIPLIESLLDIRN | 306 | Q6ZXV5 | |
| LIVREIMLEEEPSIT | 426 | Q9H6R7 | |
| EIPEIIHMTEGRELV | 141 | P17948 | |
| DEIIPTNTLEEIMLA | 1736 | Q96QT4 | |
| IEMPEELDISQLRGT | 591 | P45974 | |
| RMVNVLEPDITVIVG | 231 | Q6ZT21 | |
| RMLSLLVVDVGNPEE | 831 | P57678 | |
| MALQVELVPTGEIIR | 1 | O00159 | |
| GSEMILERLLNLVPT | 1401 | Q13402 |